109 related articles for article (PubMed ID: 2822456)
21. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
[TBL] [Abstract][Full Text] [Related]
22. Peripheral adrenergic stimulation and indomethacin in experimental ocular shedding of HSV.
Santos C; Briones O; Dawson CR
Curr Eye Res; 1987 Jan; 6(1):111-8. PubMed ID: 3030633
[TBL] [Abstract][Full Text] [Related]
23. Herpesvirus in sensory and autonomic ganglia after eye infection.
Martin RG; Dawson CR; Jones P; Togni B; Lyons C; Oh JO
Arch Ophthalmol; 1977 Nov; 95(11):2053-6. PubMed ID: 200208
[TBL] [Abstract][Full Text] [Related]
24. Timolol induces HSV-1 ocular shedding in the latently infected rabbit.
Hill JM; Shimomura Y; Dudley JB; Berman E; Haruta Y; Kwon BS; Maguire LJ
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):585-90. PubMed ID: 3030959
[TBL] [Abstract][Full Text] [Related]
25. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty.
Beyer CF; Arens MQ; Hill GA; Rose BT; Beyer LR; Schanzlin DJ
Arch Ophthalmol; 1989 Aug; 107(8):1200-5. PubMed ID: 2547352
[TBL] [Abstract][Full Text] [Related]
26. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
Townsend JJ; Baringer JR
Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
[TBL] [Abstract][Full Text] [Related]
27. Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease.
Metcalf JF; Koga J; Chatterjee S; Whitley RJ
Curr Eye Res; 1987 Jan; 6(1):173-7. PubMed ID: 3030642
[TBL] [Abstract][Full Text] [Related]
28. HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation.
Shimomura Y; Dudley JB; Gangarosa LP; Hill JM
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):121-5. PubMed ID: 2981786
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
[TBL] [Abstract][Full Text] [Related]
30. HSV-specific IgA from tears blocks virus attachment to the cell membrane.
Malaty R; Gebhardt BM; Franklin RM
Curr Eye Res; 1988 Mar; 7(3):313-20. PubMed ID: 2834142
[TBL] [Abstract][Full Text] [Related]
31. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
32. Vanadate promotes reactivation and iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals.
Gordon YJ; Romanowski E; Berman J; Vikoren P; Lin LS; Schlessinger D; Araullo-Cruz T
Curr Eye Res; 1990 Oct; 9(10):1015-21. PubMed ID: 2177389
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.
Kurata T; Kurata K; Aoyama Y
Jpn J Exp Med; 1978 Oct; 48(5):427-35. PubMed ID: 219274
[TBL] [Abstract][Full Text] [Related]
34. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of murine latent HSV infection by epinephrine iontophoresis.
Willey DE; Trousdale MD; Nesburn AB
Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):945-50. PubMed ID: 6086546
[TBL] [Abstract][Full Text] [Related]
36. Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice.
Kastrukoff LF; Lau AS; Leung GY; Thomas EE
J Neurol Sci; 1993 Jul; 117(1-2):148-58. PubMed ID: 8410049
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous ocular shedding of HSV-1 in latently infected rabbits.
Berman EJ; Hill JM
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):587-90. PubMed ID: 2984140
[TBL] [Abstract][Full Text] [Related]
39. HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine.
Shimomura Y; Gangarosa LP; Kataoka M; Hill JM
Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1588-94. PubMed ID: 6418684
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of passive immunization on herpetic retinitis of newborn rabbits.
Friedlaender RP; Oh JO; Minasi P; Ohashi Y
Curr Eye Res; 1987 Jan; 6(1):161-6. PubMed ID: 3030640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
